Lifelong caloric restriction reprograms hepatic fat metabolism in mice

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 69, Issue 8, 2014, Pages 915-922

  Kuhla, Angela ^a   Hahn, Steffi ^a   Butschkau, Antje ^a   Lange, Sophie ^a   Wree, Andreas ^a   Vollmar, Brigitte ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Adropin; FGF21; Ketogenesis; Leptin; Lipolysis

Indexed keywords

ADROPIN; ENHO PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 21; LEPTIN; PROTEIN;

ADAPTATION; ANIMAL; ARTICLE; BODY WEIGHT; C57BL MOUSE; CALORIC RESTRICTION; CHEMISTRY; ENERGY METABOLISM; FEMALE; FGF21; IMMUNOHISTOCHEMISTRY; INTRAABDOMINAL FAT; KETOGENESIS.; LIPOGENESIS; LIPOLYSIS; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; UPREGULATION; WESTERN BLOTTING;

ADROPIN; FGF21; KETOGENESIS.; LEPTIN; LIPOLYSIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CALORIC RESTRICTION; ENERGY METABOLISM; FEMALE; FIBROBLAST GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; INTRA-ABDOMINAL FAT; LIPOGENESIS; LIVER; MICE; MICE, INBRED C57BL; PROTEINS; UP-REGULATION;

EID: 84899009442     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glt160     Document Type: Article

References (38)

1. Weindruch R. Caloric restriction and aging. Sci Am. 1996;274:46-52.
2. Mulligan JD, Stewart AM, Saupe KW. Downregulation of plasma insulin levels and hepatic PPARgamma expression during the first week of caloric restriction in mice. Exp Gerontol. 2008;43:146-153.
3. Ingram DK, Zhu M, Mamczarz J, et al. Calorie restriction mimetics: an emerging research field. Aging Cell. 2006;5:97-108.
4. Wolf G. Calorie restriction increases life span: a molecular mechanism. Nutr Rev. 2006;64(2 Pt 1):89-92.
5. Mendelsohn AR, Larrick JW. Fibroblast growth factor-21 is a promising dietary restriction mimetic. Rejuvenation Res. 2012;15:624-628.
6. Nishimura T, Nakatake Y, Konishi M, Itoh N. Identification of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim Biophys Acta. 2000;1492:203-206.
7. Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS, Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metab. 2007;5:426-437.
8. Inagaki T, Dutchak P, Zhao G, et al. Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 2007;5:415-425.
9. Lundåsen T, Hunt MC, Nilsson LM, et al. PPARalpha is a key regulator of hepatic FGF21. Biochem Biophys Res Commun. 2007;360:437-440.
10. Berger J, Moller DE. The mechanisms of action of PPARs. Annu Rev Med. 2002;53:409-435.
11. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature. 1996;383:728-731.
12. Song C, Liao S. Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha. Endocrinology. 2000;141:4180-4184.
13. Baranowski M. Biological role of liver X receptors. J Physiol Pharmacol. 2008;59(suppl 7):31-55.
14. Langmann T, Klucken J, Reil M, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun. 1999;257:29-33.
15. Santamarina-Fojo S, Remaley AT, Neufeld EB, Brewer HB Jr. Regulation and intracellular trafficking of the ABCA1 transporter. J Lipid Res. 2001;42:1339-1345.
16. Feng Y, Lievens J, Jacobs F, et al. Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis. Cardiovasc Res. 2010;88:376-385.
17. Kuhla A, Blei T, Jaster R, Vollmar B. Aging is associated with a shift of fatty metabolism toward lipogenesis. J Gerontol A Biol Sci Med Sci. 2011;66:1192-1200.
18. Rosenbaum M, Sy M, Pavlovich K, Leibel RL, Hirsch J. Leptin reverses weight loss-induced changes in regional neural activity responses to visual food stimuli. J Clin Invest. 2008;118:2583-2591.
19. Leibel RL. The role of leptin in the control of body weight. Nutr Rev. 2002;60(10 Pt 2):S15-9; discussion S68.
20. Rosenbaum M, Leibel RL. Adaptive thermogenesis in humans. Int J Obes (Lond). 2010;34(suppl 1):S47-S55.
21. Frederich RC, Hamann A, Anderson S, Löllmann B, Lowell BB, Flier JS. Leptin levels reflect body lipid content in mice: evidence for dietinduced resistance to leptin action. Nat Med. 1995;1:1311-1314.
22. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature. 1996;382:250-252.
23. Lecoultre V, Ravussin E, Redman LM. The fall in leptin concentration is a major determinant of the metabolic adaptation induced by caloric restriction independently of the changes in leptin circadian rhythms. J Clin Endocrinol Metab. 2011;96:E1512-E1516.
24. Shimokawa I, Higami Y. Leptin signaling and aging: insight from caloric restriction. Mech Ageing Dev. 2001;122:1511-1519.
25. Kumar KG, Trevaskis JL, Lam DD, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468-481.
26. Bruss MD, Khambatta CF, Ruby MA, Aggarwal I, Hellerstein MK. Calorie restriction increases fatty acid synthesis and whole body fat oxidation rates. Am J Physiol Endocrinol Metab. 2010;298:E108-E116.
27. Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol. 2008;43:859-866.
28. Wang Z, Masternak MM, Al-Regaiey KA, Bartke A. Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology. 2007;148:2845-2853.
29. Bligh EG, Dyer WJ. Arapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-917.
30. Edwards PA, Kennedy MA, Mak PA. LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis. Vascul Pharmacol. 2002;38:249-256.
31. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ. 2005;172:899-905.
32. Sanal MG. The blind men 'see' the elephant-the many faces of fatty liver disease. World J Gastroenterol. 2008;14:831-844.
33. Fulop T, Tessier D, Carpentier A. The metabolic syndrome. Pathol Biol. 2006;54:375-386.
34. Ozanne SE, Hales CN. Pre-and early postnatal nongenetic determinants of type 2 diabetes. Expert Rev Mol Med. 2002;4:1-14.
35. Takemori K, Kimura T, Shirasaka N, Inoue T, Masuno K, Ito H. Food restriction improves glucose and lipid metabolism through Sirt1 expression: a study using a new rat model with obesity and severe hypertension. Life Sci. 2011;88:1088-1094.
36. Yakubovskaya, VI. The effect of fasting on the cholesterol metabolism. Biochem. Biophys. 1960;50:87-89.
37. Domouzoglou EM, Maratos-Flier E. Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis. Am J Clin Nutr. 2011;93:901S-9015.
38. Vilà-Brau A, De Sousa-Coelho AL, Mayordomo C, Haro D, Marrero PF. Human HMGCS2 regulates mitochondrial fatty acid oxidation and FGF21 expression in HepG2 cell line. J Biol Chem. 2011;286:20423-20430.